Sitemap > Breaking Research > Cardiovascular Disorders
Displaying 1651 - 1700 of 4862 results
- A multi-country economic evaluation of low-dose aspirin in the primary prevention of cardiovascular disease.
- Coagulation and metastasis--an unexpected role for von Willebrand factor.
- Cancer and subsequent risk of venous thromboembolism.
- Incidence of venous thromboembolism following major abdominal surgery: a multi-center, prospective epidemiological study in Japan.
- Discovery of novel heterocyclic factor VIIa inhibitors.
- Orally active thrombin inhibitors. Part 2: optimization of the P2-moiety.
- Histone acetyltransferase activity of p300 is required for the promotion of left ventricular remodeling after myocardial infarction in adult mice in vivo.
- Adipocyte enhancer-binding protein 1 is a potential novel atherogenic factor involved in macrophage cholesterol homeostasis and inflammation.
- Smooth muscle of telokin-deficient mice exhibits increased sensitivity to Ca2+ and decreased cGMP-induced relaxation.
- Natural regulatory T cells control the development of atherosclerosis in mice.
- Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus: relationship to cardiovascular risk factors.
- Myocardial stiffness is an important determinant of the plasma brain natriuretic peptide concentration in patients with both diastolic and systolic heart failure.
- The intrinsic pathway of coagulation is essential for thrombus stability in mice.
- Stem cell factor receptor induces progenitor and natural killer cell-mediated cardiac survival and repair after myocardial infarction.
- Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial.
- Treatment with an inhibitory monoclonal antibody to mouse factor B protects mice from induction of apoptosis and renal ischemia/reperfusion injury.
- NXY-059 for acute ischemic stroke.
- Hypertension after experimental cerebral ischemia: candesartan provides neurovascular protection.
- Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study)*.
- Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study.
- Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients.
- Prevalence, awareness, treatment, and control of hypertension: United States National Health and Nutrition Examination Survey 2001-2002.
- Providing end-organ protection with renin-angiotensin system inhibition: the evidence so far.
- Predictive value of the serum level of N-terminal pro-brain natriuretic peptide and high-sensitivity C-reactive protein in left ventricular remodeling after acute myocardial infarction.
- The effect of different doses of fluvastatin on inflammatory markers in the early phase of acute coronary syndrome.
- Ether à go-go potassium channels and cancer.
- Vasohibin is up-regulated by VEGF in the retina and suppresses VEGF receptor 2 and retinal neovascularization.
- Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response.
- Worldwide management of oral anticoagulant therapy: the ISAM study.
- Effect of statins and white blood cell count on mortality in patients with ischemic left ventricular dysfunction undergoing percutaneous coronary intervention.
- Effects of amlodipine orotate on hypertension-related complications in spontaneously hypertensive rats.
- Cardiovascular effects of KUR-1246, a new tetrahydronaphthalen derivative beta2-adrenoceptor agonist and a selective uterine relaxant.
- Cytoprotective gene bi-1 is required for intrinsic protection from endoplasmic reticulum stress and ischemia-reperfusion injury.
- Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial.
- B-type natriuretic peptide (BNP) and N-terminal-proBNP for heart failure diagnosis in shock or acute respiratory distress.
- Vardenafil: a novel type 5 phosphodiesterase inhibitor reduces myocardial infarct size following ischemia/reperfusion injury via opening of mitochondrial K(ATP) channels in rabbits.
- Ketopiperazine-based renin inhibitors: optimization of the "C" ring.
- Hydroxyl-terminated peptidomimetic inhibitors of neuronal nitric oxide synthase.
- The role of beta2-glycoprotein I (beta2GPI) in the activation of plasminogen.
- Class III effects of dofetilide and arrhythmias are modulated by [K+]o in an in vitro model of simulated-ischemia and reperfusion in guinea-pig ventricular myocardium.
- Analysis of calstabin2 (FKBP12.6)-ryanodine receptor interactions: rescue of heart failure by calstabin2 in mice.
- Physiology and pathophysiology of Na+/H+ exchange and Na+ -K+ -2Cl- cotransport in the heart, brain, and blood.
- Potential role of poly(adenosine 5'-diphosphate-ribose) polymerase activation in the pathogenesis of myocardial contractile dysfunction associated with human septic shock.
- Treatment and one-year outcome of patients with renal dysfunction across the broad spectrum of acute coronary syndromes.
- Demographics, treatment and outcome of acute coronary syndromes: 17 years of experience in a specialized cardiac centre.
- Long-term symptomatic benefit after radiofrequency catheter ablation for atrial flutter despite a high incidence of post-procedural atrial fibrillation.
- Pharmacokinetics of darbepoetin alfa after intravenous or subcutaneous administration in patients with non-myeloid malignancies undergoing chemotherapy.
- Discovery of novel hydroxy pyrazole based factor IXa inhibitor.
- Cardiac progenitor cells in brown adipose tissue repaired damaged myocardium.
- Slowing of the inactivation of voltage-dependent sodium channels by staurosporine, the protein kinase C inhibitor, in rabbit atrial myocytes.
< Previous 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 Next >